SCHEMBL14035013

SCHEMBL14035013

CC12CCCC(C1)C(N)CC2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8337941 0.75
SCHEMBL18952210 0.69 ALDH1A1 (0.43) ALDH1A1
SCHEMBL1164719 0.67
SCHEMBL6591834 0.66 GRIN1 (0.33) ALDH1A1
SCHEMBL28262988 0.65 ALDH1A1 (0.35) ALDH1A1
SCHEMBL10619687 0.62 EPHX2 (0.30)
SCHEMBL23355975 0.61 ALDH1A1 (0.36) ALDH1A1
SCHEMBL6818818 0.61
SCHEMBL17049001 0.61 ALDH1A1 (0.33) ALDH1A1
SCHEMBL17098246 0.61 ALDH1A1 (0.34) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 WO disclosed
US-7456222-B2 Anti tubercular drug: compositions and methods SEQUELLA, INC. (US) 2008-11-25 US disclosed